Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2096619 Target Snapshot

Phosphatidylinositol 4-kinase, PI4K · PROTEIN FAMILY · Homo sapiens

93Compounds
12Assays
2Approved Drugs
125.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9BTU6. Use UniProt Q9BTU6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9BTU6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Phosphatidylinositol 4-kinase, PI4K as ChEMBL target CHEMBL2096619, mapped to UniProt Q9BTU6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Phosphatidylinositol 4-kinase, PI4K
PROTEIN FAMILY · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2096619
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9BTU6
Phosphatidylinositol 4-kinase type 2-alpha
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Phosphatidylinositol 4-kinase, PI4K is the right protein anchor across sources, using UniProt Q9BTU6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPhosphatidylinositol 4-kinase type 2-alpha
UniProt AccessionQ9BTU6
Component TypeProtein
Sequence Length479 aa

Phosphatidylinositol 4-kinase type 2-alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Phosphatidylinositol 4-kinase, PI4K, mapped to UniProt Q9BTU6. ChEMBL maps the protein component as Phosphatidylinositol 4-kinase type 2-alpha. Sequence length is 479 aa.

Mapped IDQ9BTU6
Review namePhosphatidylinositol 4-kinase, PI4K
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC5074.0
KI51.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL63783 5.43 Ki 3700.0 Preclinical
CHEMBL293027 5.39 Ki 4100.0 Preclinical
CHEMBL413106 5.3 Ki 5000.0 Preclinical
CHEMBL62835 5.3 Ki 5000.0 Preclinical
CHEMBL293027 5.22 IC50 6000.0 Preclinical
CHEMBL63783 5.22 IC50 6000.0 Preclinical
CHEMBL294590 5.22 Ki 6000.0 Preclinical
CHEMBL306444 5.16 Ki 6900.0 Preclinical
CHEMBL21619 5.15 IC50 7100.0 Preclinical
CHEMBL413106 5.14 IC50 7200.0 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
0
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

12
Total Assays
53
Tested Compounds
2
Assay Types
Binding — 10 assays, 53 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 8 53 4.6
cell-based format 2 0
Functional — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine